References
- Safiri S, Kolahi A, Smith E, et al. Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the global burden of disease study 2017. Ann Rheum Dis. 2020;79(6):819–828.
- Marshall D, Liu X, Barnabe C, et al. Existing comorbidities in people with osteoarthritis: a retrospective analysis of a population-based cohort in Alberta, Canada. BMJ Open. 2019;9(11):e033334.
- Whelton P, Carey R, Aronow W, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Hypertension. 2018;71(6):1269–1324.
- Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2020;72(2):149–162.
- Consensi [package insert]. Tel Aviv, Israel: Kitov Pharma Ltd; 2018
- Goldstein RE, Boccuzzi SJ, Cruess D, et al. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The adverse experience committee; and the multicenter diltiazem postinfarction research group. Circulation. 1991;83:52–60.
- Elkayam U, Amin J, Mehra A, et al. A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. Circulation. 1990;82:1954–1961.
- Packer M, Lee WH, Medina N, et al. Prognostic importance of the immediate hemodynamic response to nifedipine in patients with severe left ventricular dysfunction. J Am Coll Cardiol. 1987;10:1303–1311.
- The ALLHAT officers and coordinators for the allhat collaborative research group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA. 2002;288:2981–2997.
- Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359:2417–2428.
- Bannuru R, Osani M, Vaysbrot E, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019;27(11):1578–1589.
- MEPS topics: prescription drugs [internet]. Rockville, MD: Agency for Healthcare Research and Quality. [cited 2020 Dec 6]. Available from: https://meps.ahrq.gov/mepsweb/data_stats/MEPS_topics.jsp?topicid=14Z-1
- Bouck Z, Mecredy G, Ivers N, et al. Frequency and associations of prescription nonsteroidal anti-inflammatory drug use among patients with a musculoskeletal disorder and hypertension, heart failure, or chronic kidney disease. JAMA Intern Med. 2018;178(11):1516–1525.
- Hwang A, Dave C, Smith SM. Use of prescription medications that potentially interfere with blood pressure control in new-onset hypertension and treatment-resistant hypertension. Am J Hypertens. 2018;31(12):1324–1331.
- Kitov Pharma Ltd. Study to evaluate the effect of celecoxib on the efficacy and safety of amlodipine in subjects with hypertension requiring antihypertensive therapy. NLM identifier: NCT02172040. 2017. Accessed 2020 Dec 6. Available from: https://clinicaltrials.gov/ct2/show/results/NCT02172040.
- Kitov Pharma Ltd. Evaluation of celecoxib effects on amlodipine in subjects with existing hypertension requiring antihypertensives. Accessed 2020 Dec 6. Available from: https://clinicaltrials.gov/ct2/show/study/NCT02979197.
- Whelton A, White W, Bello A. Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis. Am J Cardiol. 2002;90(9):959–963.
- Houston M, Weir M, Gray J. The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil. Arch Intern Med. 1995;155(10):1049–1054.
- Morgan TO, Anderson A, Bertram D. Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril. Am J Hypertens. 2000;13(11):1161–1167.
- Solomon SD, McMurray JJV, Pfeffer MA, et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med. 2005;352(11):1071–1080.
- GoodRx [internet]. Santa Monica, CA: GoodRx; c2020 [updated 2020 Dec, cited 2020 Dec 6]. Available from: https://www.goodrx.com/consensi